WebMayne Pharma Lisa Pendlebury (VP Investor Relations & Communications) +61 419 548 434 - [email protected] Mithra Christophe Maréchal (Investor) : +32 … Web13 okt. 2024 · Mayne Pharma controls 53.5% of INTI and has consolidated 100% of INTI, in accordance with accounting standards, into the financial statements following this …
Associate. Vice President to Vice President, Investor Relations
WebMayne Pharma May 2024 - Present2 years Territory Sales Consultant Agile Therapeutics Aug 2024 - May 202410 months Menopause Specialty … WebMayne Pharma is committed to providing high levels of service and our experienced in-house Patient & Provider Services Team is here to help. For US product enquiries call us … projector with flashlight app android
Results and Reports - Mayne Pharma Group Limited
Web1 dag geleden · That’s pretty gob-smacking growth during a period of such high inflation. Ranking behind Lovisa — by a long way — are these four other ASX 200 retail shares … WebMayne Pharma is a specialty pharmaceutical company listed on the Australian Securities Exchange (ASX: MYX). The company develops and manufactures branded and generic … WebTherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD) … projector with flashlight app